Monitoring of Epstein–Barr virus load in patients after allogeneic hematopoietic stem cell transplantation

Varování

Publikace nespadá pod Filozofickou fakultu, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

VOLFOVÁ Pavlína LENGEROVÁ Martina WINTEROVÁ Jana RÁČIL Zdeněk DVOŘÁKOVÁ Dana MAYER Jiří

Rok publikování 2012
Druh Článek v odborném periodiku
Časopis / Zdroj Infection
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.1007/s15010-012-0262-5
Obor Onkologie a hematologie
Klíčová slova Epstein–Barr virus; hematopoietic stem cell transplantation
Přiložené soubory
Popis Based on our results, we recommend the weekly monitoring of patients for at least 3 months after HSCT (2 out of 4 patients with EBV-associated disease passed the cut-off at week 11) and longer in patients with GVHD, due to the rapid progression of EBV infection, particularly in patients who develop clinical symptoms (lymphadenopathy, hepatosplenomegaly, or organ manifestations) related to EBV disease according to the European Conference on Infections in Leukemia (ECIL) 2011 guidelines. EBV reactivation occurred in some of the patients suffering fromGVHDin this cohort, but did not require clinical intervention unless the copy numbers were steadily increasing. A stable EBV viral load\1,000 copies/lg DNA temporarily occurred in some patients after HSCT; however, clinical symptoms of EBV infection did not develop and they did not require therapeutic intervention. Therefore, to improve the diagnostic value of EBV monitoring, the load measurement and quantitative monitoring of viral load kinetics is necessary.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.